Prognostic Factor | HazardRatio | 95% CI | P |
---|---|---|---|
Age(<60 vs ≥60) | 0.890 | 0.637–1.243 | 0.495 |
Sex (Male vs Female) | 0.722 | 0.503–1.304 | 0.076 |
Primary tumor location (baseline, Upper) | Â | Â | 0.010 |
 Middle | 1.292 | 0.948–1.761 | 0.105 |
 Lower | 1.790 | 1.229–2.607 | 0.002 |
T category (baseline, T2) | Â | Â | 0.013 |
 T3 | 1.171 | 0.795–1.724 | 0.425 |
 T4 | 1.827 | 1.162–2.872 | 0.009 |
No. of LNs (N0, < 3 vs ≥3) | 1.667 | 1.177–2.361 | 0.004 |
Extent of LNs (baseline, N0) | Â | Â | 0.044 |
 1 region | 1.365 | 0.834–2.087 | 0.125 |
 2 regions | 1.575 | 0.989–2.508 | 0.056 |
 3 regions | 2.475 | 1.178–5.159 | 0.016 |
Size of LNs (N0, ≤2 vs > 2 cm) | 0.812 | 0.527–1.252 | 0.347 |
Treatment (CRT vs RT alone) | 0.569 | 0.425–0.762 | 0.001 |